Agrawal Medicaments Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -22403.56%
- Ebitda -22274.72%
- Net Worth -5468.03%
- Total Assets 276.99%
About Agrawal Medicaments
Agrawal Medicaments Private Limited (AMPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 December 2012 and has a history of 12 years and one month. Its registered office is in Goa, Goa, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Krishnakumar Agrawal, Anirudh Agrawal, and Anurag Agrawal serve as directors at the Company.
Company Details
-
Location
Goa, Goa, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24119GA2012PTC007117
-
Company No.
007117
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Dec 2012
-
Date of AGM
25 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Goa
Industry
Who are the key members and board of directors at Agrawal Medicaments?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anirudh Agrawal
|
Director | 07-Dec-2012 | Current |
|
Krishnakumar Agrawal
|
Director | 07-Dec-2012 | Current |
|
Anurag Agrawal
|
Director | 07-Dec-2012 | Current |
Financial Performance of Agrawal Medicaments.
Agrawal Medicaments Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 22403.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 5468.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agrawal Medicaments?
In 2017, Agrawal Medicaments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kayji Real Estate Private Limited.Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
-
Dci Pharmaceuticals Private LimitedKrishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
-
Agrawal Minerals (Goa) Private LimitedKrishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
-
Aryavaan Pharmaceuticals Private Limited
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
-
Medizest Pharmaceuticals Private Limited
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
-
Tyresoles Goa Private Limited
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Agrawal Medicaments?
Agrawal Medicaments has a workforce of 1 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agrawal Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agrawal Medicaments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.